BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 22332886)

  • 1. Urinary titanium and vanadium and breast cancer: a case-control study.
    Tang LY; Su Y; He JR; Chen WQ; Su FX; Wu BH; Lin Y; Ren ZF
    Nutr Cancer; 2012 Apr; 64(3):368-76. PubMed ID: 22332886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary rubidium in breast cancers.
    Su Y; Chen LJ; He JR; Yuan XJ; Cen YL; Su FX; Tang LY; Zhang AH; Chen WQ; Lin Y; Wang SM; Ren ZF
    Clin Chim Acta; 2011 Nov; 412(23-24):2305-9. PubMed ID: 21910977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary strontium and the risk of breast cancer: a case-control study in Guangzhou, China.
    Chen LJ; Tang LY; He JR; Su Y; Cen YL; Yu DD; Wu BH; Lin Y; Chen WQ; Song EW; Ren ZF
    Environ Res; 2012 Jan; 112():212-7. PubMed ID: 22172139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary phytoestrogens and postmenopausal breast cancer risk.
    den Tonkelaar I; Keinan-Boker L; Veer PV; Arts CJ; Adlercreutz H; Thijssen JH; Peeters PH
    Cancer Epidemiol Biomarkers Prev; 2001 Mar; 10(3):223-8. PubMed ID: 11303591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary estrogen metabolites and breast cancer: a case-control study.
    Kabat GC; Chang CJ; Sparano JA; Sepkovie DW; Hu XP; Khalil A; Rosenblatt R; Bradlow HL
    Cancer Epidemiol Biomarkers Prev; 1997 Jul; 6(7):505-9. PubMed ID: 9232337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modified effect of urinary cadmium on breast cancer risk by selenium.
    Wei XL; He JR; Cen YL; Su Y; Chen LJ; Lin Y; Wu BH; Su FX; Tang LY; Ren ZF
    Clin Chim Acta; 2015 Jan; 438():80-5. PubMed ID: 25149105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adipocytokine resistin and breast cancer risk.
    Sun CA; Wu MH; Chu CH; Chou YC; Hsu GC; Yang T; Chou WY; Yu CP; Yu JC
    Breast Cancer Res Treat; 2010 Oct; 123(3):869-76. PubMed ID: 20177966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lifetime physical activity and the risk of breast cancer: a case-control study.
    Kruk J
    Cancer Detect Prev; 2007; 31(1):18-28. PubMed ID: 17296272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cadmium exposure and breast cancer risk.
    McElroy JA; Shafer MM; Trentham-Dietz A; Hampton JM; Newcomb PA
    J Natl Cancer Inst; 2006 Jun; 98(12):869-73. PubMed ID: 16788160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin, macronutrient intake, and physical activity: are potential indicators of insulin resistance associated with mortality from breast cancer?
    Borugian MJ; Sheps SB; Kim-Sing C; Van Patten C; Potter JD; Dunn B; Gallagher RP; Hislop TG
    Cancer Epidemiol Biomarkers Prev; 2004 Jul; 13(7):1163-72. PubMed ID: 15247127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary melatonin levels and breast cancer risk.
    Schernhammer ES; Hankinson SE
    J Natl Cancer Inst; 2005 Jul; 97(14):1084-7. PubMed ID: 16030307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fasting glucose is a risk factor for breast cancer: a prospective study.
    Muti P; Quattrin T; Grant BJ; Krogh V; Micheli A; Schünemann HJ; Ram M; Freudenheim JL; Sieri S; Trevisan M; Berrino F
    Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1361-8. PubMed ID: 12433712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of urinary cesium with breast cancer risk.
    Qin YC; Tang LY; Su Y; Chen LJ; Su FX; Lin Y; Zhang AH; Ren ZF
    Asian Pac J Cancer Prev; 2014; 15(22):9785-90. PubMed ID: 25520105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic polymorphisms of the methylenetetrahydrofolate reductase gene, plasma folate levels and breast cancer susceptibility: a case-control study in Taiwan.
    Chou YC; Wu MH; Yu JC; Lee MS; Yang T; Shih HL; Wu TY; Sun CA
    Carcinogenesis; 2006 Nov; 27(11):2295-300. PubMed ID: 16777985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum fatty acids and risk of breast cancer in a nested case-control study of the New York University Women's Health Study.
    Saadatian-Elahi M; Toniolo P; Ferrari P; Goudable J; Akhmedkhanov A; Zeleniuch-Jacquotte A; Riboli E
    Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1353-60. PubMed ID: 12433711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early-life physical activity and postmenopausal breast cancer: effect of body size and weight change.
    Shoff SM; Newcomb PA; Trentham-Dietz A; Remington PL; Mittendorf R; Greenberg ER; Willett WC
    Cancer Epidemiol Biomarkers Prev; 2000 Jun; 9(6):591-5. PubMed ID: 10868694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-like growth factors and breast cancer risk in Chinese women.
    Yu H; Jin F; Shu XO; Li BD; Dai Q; Cheng JR; Berkel HJ; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2002 Aug; 11(8):705-12. PubMed ID: 12163322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum concentrations of organochlorine compounds and the subsequent development of breast cancer.
    Helzlsouer KJ; Alberg AJ; Huang HY; Hoffman SC; Strickland PT; Brock JW; Burse VW; Needham LL; Bell DA; Lavigne JA; Yager JD; Comstock GW
    Cancer Epidemiol Biomarkers Prev; 1999 Jun; 8(6):525-32. PubMed ID: 10385143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary carotenoids and risk of breast cancer in Chinese women.
    Huang JP; Zhang M; Holman CD; Xie X
    Asia Pac J Clin Nutr; 2007; 16 Suppl 1():437-42. PubMed ID: 17392146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.